Breaking

Michael Anne Kyle embarked on her journey to simplify the patient experience in healthcare after hearing complaints from her friends about the complexities they faced in the system. As both a Ph.D. student at...

As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or connecting with loved ones, there are plenty of ways to...

First Opinion is a platform on STAT where experts in the field of life sciences share their thoughts and opinions. Readers can also submit Letters to the Editor in response to these articles for...

GLP-1 drugs like Wegovy and Zepbound are becoming increasingly popular among individuals with obesity, leading to a decline in the demand for bariatric surgery. A recent study examined health records of 17 million privately...

Are you excited about a new hire or a promotion in your workplace? Don't keep it to yourself! Share the news with us, and we'll help spread the word. It's always interesting to know...

UnitedHealth Group, the nation's largest health insurer, is facing serious allegations of abusing the federal Medicare program for financial gain. A recent federal report uncovered that UnitedHealth was diagnosing patients with chronic illnesses such...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. A new way to test babies for diseases that current screening methods don’t catch Newborn babies are...

Health AI startups are seeing rapid growth according to a report by Bessemer Venture Partners. The report highlights that AI software services in healthcare are reaching $10 million in annual revenue at a much...

President Trump had to cancel his plan to talk with Robert F. Kennedy Jr. about chronic illnesses and their causes under the “Make America Healthy Again” banner due to scheduling conflicts. Even though the...

Pfizer, a pharmaceutical giant, is facing potential changes due to an activist investor campaign. The future of the company, including the possibility of CEO Albert Bourla being replaced, is being questioned. Additionally, the failed...

Good morning! If you aren’t already subscribed to DC Diagnosis, the newsletter from our amazing reporters down in DC, what are you doing? Have some coffee Pharmalot-style, then get on that.Overwhelming evidence shows that...

Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...